After the FDA recently reclassified osteogenesis stimulators as class II devices, claims with certain HCPCS codes should no longer include modifier -KF.
NAHRI is excited to host the ninth annual Revenue Integrity Week, which will be held June 1-5, 2026. Get updates on exclusive Revenue Integrity Week events and resources by signing up for NAHRI's free weekly enewsletter. Download the free 2026 Revenue Integrity Week Toolkit, including posters, an FAQ, games, suggested activities, and more.
Gain expert insights into the nuances of how CMS' rules affect reimbursement and what revenue integrity can do to protect compliant revenue and adapt to changes.
UnitedHealthcare recently announced its plans to cut prior authorization requirements for 30% of services that previously required insurer approval by the end of 2026.
